In this study, our findings reveal that MB21D2 knockdown increases the expression of Wnt3A, β-catenin, and other related factors in the Wnt/β-catenin pathway, promoting a malignant phenotype in ESCC cells. The gene discussed is WNT3A; the disease is esophageal squamous cell carcinoma.